MedTrace Logo

Treatment and Exacerbation in COPD Subjects

NCT03375450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60243

Last updated 2020-09-14

No results posted yet for this study

Summary

This is a study comparing the effects of ICS containing treatments in patients with chronic obstructive pulmonary disease (COPD) in a real world setting, using the UK Clinical Practice Research Datalink (CPRD) linked with Hospital Episode Statistics (HES). The main outcome to be assessed is exacerbation rates.

Conditions

  • Comparative Effectiveness Study

Interventions

OTHER

Standard of Care

Participants will be followed as per local routine primary healthcare practice

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-09
Primary Completion
2019-08-30
Completion
2019-08-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03375450 on ClinicalTrials.gov